Differential effects of reserpine and 6-hydroxydopamine on neuropeptide Y (NPY) and noradrenaline in peripheral neurons
- PMID: 2858824
- DOI: 10.1007/BF00515563
Differential effects of reserpine and 6-hydroxydopamine on neuropeptide Y (NPY) and noradrenaline in peripheral neurons
Abstract
The effects of 6-hydroxydopamine (6-OHDA) and reserpine pretreatment on peripheral neuropeptide Y (NPY)- and noradrenaline (NA)-containing neurons were studied in guinea-pigs. Ten days after 6-OHDA pretreatment, a 60-80% reduction of the NA content was observed in the right atrium of the heart, stellate ganglion and spleen. The content of NPY-like immunoreactivity (LI) was reduced by about 50% in the heart, not changed in the spleen while it increased to 200% of control in the stellate ganglion. Immunohistochemistry showed a pronounced loss of NPY- and tyrosinehydroxylase (TH)-immunoreactive (IR) nerves in the heart but not in the spleen. Increased NPY-IR was seen in axons and cell bodies of the stellate ganglion. Reserpine pretreatment (thereshold dose 0.5 mg X kg-1) caused a dose- and time-dependent reduction of the content of NPY-LI in the heart. A maximal depletion of NPY-LI (about 80%) was observed 5 days after reserpine. Reserpine pretreatment also reduced the content of NPY-LI in the spleen, while no significant change was observed in the adrenal gland or vas deferens. The levels of NPY-LI increased in the stellate ganglion to about 180% of control 5 days after reserpine. Immunohistochemical analysis revealed an almost total loss of NPY-IR nerve fibres in the heart as well as around blood vessels in the lung and skeletal muscle. No detectable changes were observed in perivascular NPY-IR nerves in the spleen, vas deferens or kidney. TH-IR nerves remained unchanged after reserpine, thus indicating that the observed loss of NPY-IR nerves was due to a depletion of NPY and not a degeneration. No change in the levels of substance P-LI was observed in the right atrium 5 days after reserpine. NA was, in contrast to NPY, markedly depleted in all tissues investigated after reserpine treatment. The depletion of NA was more extensive, and occurred more rapidly and at much lower doses as compared to the effects on NPY-LI. Ligations of the sciatic nerve revealed that NPY-LI was transported axonally with a rapid rate (3 mm/h). Reserpine pretreatment significantly increased the amount of accumulated NPY-IR above the ligation, suggesting an increase in axonal transport. High performance liquid chromatography revealed that the NPY-LI consisted of two major peaks in the stellate ganglia, while only one peak closely corresponding to porcine NPY was seen in the right atrium. In conclusion, 6-OHDA pretreatment depletes NPY-LI in certain terminal regions and increases NPY-LI in ganglia.(ABSTRACT TRUNCATED AT 400 WORDS)
Similar articles
-
Reserpine-induced depletion of neuropeptide Y in the guinea-pig: tissue-specific effects and mechanisms of action.J Auton Nerv Syst. 1987 Oct;20(3):257-63. doi: 10.1016/0165-1838(87)90154-8. J Auton Nerv Syst. 1987. PMID: 3121715
-
Differential effects of clonidine and reserpine treatment on neuropeptide Y content in some sympathetically innervated tissues of the guinea-pig.Eur J Pharmacol. 1987 Oct 13;142(2):267-73. doi: 10.1016/0014-2999(87)90116-6. Eur J Pharmacol. 1987. PMID: 3691641
-
Mechanisms underlying changes in the contents of neuropeptide Y in cardiovascular nerves and adrenal gland induced by sympatholytic drugs.Acta Physiol Scand. 1985 Aug;124(4):603-11. doi: 10.1111/j.1748-1716.1985.tb00054.x. Acta Physiol Scand. 1985. PMID: 3840321
-
Pharmacology of noradrenaline and neuropeptide tyrosine (NPY)-mediated sympathetic cotransmission.Fundam Clin Pharmacol. 1990;4(4):373-91. doi: 10.1111/j.1472-8206.1990.tb00692.x. Fundam Clin Pharmacol. 1990. PMID: 2170253 Review.
-
Effects of antihypertensive drugs on sympathetic vascular control in relation to neuropeptide Y.J Cardiovasc Pharmacol. 1987;10 Suppl 12:S51-68. J Cardiovasc Pharmacol. 1987. PMID: 2455193 Review.
Cited by
-
Peptides in the mammalian cardiovascular system.Experientia. 1987 Jul 15;43(7):821-32. doi: 10.1007/BF01945360. Experientia. 1987. PMID: 3297769 Review.
-
Structure and expression of the rat neuropeptide Y gene.Proc Natl Acad Sci U S A. 1987 Apr;84(7):2068-72. doi: 10.1073/pnas.84.7.2068. Proc Natl Acad Sci U S A. 1987. PMID: 3031663 Free PMC article.
-
Characterization and presynaptic modulation of stimulation-evoked exocytotic co-release of noradrenaline and neuropeptide Y in guinea pig heart.Naunyn Schmiedebergs Arch Pharmacol. 1989 Jan-Feb;339(1-2):71-8. doi: 10.1007/BF00165129. Naunyn Schmiedebergs Arch Pharmacol. 1989. PMID: 2566928
-
Neuropeptide Y immunoreactivity in the mammalian liver: pattern of innervation and coexistence with tyrosine hydroxylase immunoreactivity.Cell Tissue Res. 1991 Aug;265(2):287-95. doi: 10.1007/BF00398076. Cell Tissue Res. 1991. PMID: 1682053
-
Modulation of cholinergic neurotransmission in guinea-pig trachea by neuropeptide Y.Br J Pharmacol. 1988 Mar;93(3):672-8. doi: 10.1111/j.1476-5381.1988.tb10325.x. Br J Pharmacol. 1988. PMID: 2836013 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Research Materials
Miscellaneous